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Employment Opportunities
Research Associate Position in Genetic Epidemiology.—TheDi-
vision of Genetic Epidemiology of the Medical University
of Innsbruck, Austria, seeks to recruit a scientist with ex-
perience in genetic epidemiology and statistical genetics.
We primarily investigate genetic risk factors for cardio-
vascular disease, with a focus on intermediate phenotypes,
as well as other complex diseases. We are applying meth-
ods of linkage analysis and association studies. Future pro-
jects will focus on genomewide association studies. It will
be the task of the successful applicant to extend or estab-
lish the necessary methods. Therefore, experience in
bioinformatic methods will be helpful. Since coworkers
and collaborative partners have to be consulted, com-
municative skills and teamwork are required. However,
the candidate should be also able to work relatively in-
dependently. It is expected that the appointee will write
grant applications and scientiﬁc articles. For a detailed in-
formation on our division and genotyping unit, as well
as the deadline for applications, please visit our Web site
(http://www.i-med.ac.at/genepi/). Please send any inquiry
concerning the position—or your informal application,
including a curriculum vitae and a statement of research
and analysis experience—as soon as possible to Dr. Florian
Kronenberg; e-mail: Florian.Kronenberg@i-med.ac.at
Assistant/Associate Professor, Cancer Pharmacogenomics.—
The University of North Carolina School of Pharmacy in-
vites applications for a tenure-track assistant/associate
professor. The successful candidate will develop andmain-
tain an externally funded translational research program,
will mentor graduate students/postdoctoral fellows, and
will contribute to the teaching mission of the Division of
Pharmacotherapy and Experimental Therapeutics. Pri-
mary research interests within the Division (and emphases
within its new graduate program) include but are not lim-
ited to pharmacogenomics, drug resistance, drug metab-
olism, drug transport, pharmacokinetics, and pharmaco-
dynamics. The Division intends to lead the nation in
achieving excellence in innovative translational research,
education, and progressive pharmacy practice to optimize
drug therapy outcomes. Collaborative research opportu-
nities exist with faculty in the Lineberger Comprehensive
Cancer Center, the Carolina Center for Genome Sciences,
and other programs in the Schools of Medicine, Public
Health, Dentistry, and Nursing. These schools make up
one of the nation’s few comprehensive academic health
centers, located on a world-class research campus. Review
of applications will continue until the position is ﬁlled.
Women and minorities are encouraged to apply. Appli-
cations, including a curriculum vitae and names and con-
tact information for four references, should be submitted
to Kim L. R. Brouwer, Pharm.D., Ph.D., School of Phar-
macy, Kerr Hall, CB #7360, University of North Carolina,
Chapel Hill, NC 27599-7360. For more information, see
the School of Pharmacy’s Web site (http://www.pharmacy
.unc.edu/). The University of North Carolina is an equal
opportunity/afﬁrmative action employer.
Meetings
12th and 13th Annual International Scientiﬁc Meetings of the
Velo-Cardio-Facial Syndrome Educational Foundation.—The
Velo-Cardio-Facial Syndrome Educational Foundation,
Inc., will be holding two annual meetings this year, the
ﬁrst in Strasbourg, France, July 7–9, 2006, and the second
in Brisbane, Australia, November 2–4, 2006. The Stras-
bourg meeting will be cosponsored and hosted by Ge´ne´r-
ation22. The international and interdisciplinary faculty at
the meeting in Strasbourg includes eminent researchers
and clinicians from France, Belgium, Great Britain, Ire-
land, Israel, Italy, Mexico, The Netherlands, Switzerland,
and the United States and will cover the latest research in
molecular genetics, psychiatric illness, speech and feeding
disorders, surgical outcomes, neural imaging, develop-
ment, and education, among other topics. The ofﬁcial lan-
guages of the meeting will be English and French, with
simultaneous translation of all presentations. The regis-
tration fee is i35 ($42 U.S.) per person. Additional infor-
mation is available at the Educational Foundation’s Web
site (http://www.vcfsef.org). Additional information may
also be obtained from the Ge´ne´ration22 Web site (http:
//www.generation22.asso.fr). The Brisbanemeetingwill be
cosponsored and hosted by The VCFS Foundation (Qld),
Inc. The international and interdisciplinary faculty at the
meeting in Brisbane is being assembled and will include
eminent researchers and clinicians covering the latest re-
search in genetics and genomics, speech and feeding dis-
orders, surgical outcomes, psychiatric illness, neural im-
aging, development, and education, among other topics.
Details will follow in the coming months and will be
available at the Web sites of the Educational Foundation
(http://www.vcfsef.org) and The VCFS Foundation (Qld),
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Inc. (http://www.vcfs.com.au). The meetings are open to
all professionals and laypeople with an interest in the
disorder. The Velo-Cardio-Facial Syndrome Educational
Foundation, Inc., is an international alliance of profes-
sionals and laypeople whose mission is to spread infor-
mation about VCFS (also known as “DiGeorge syndrome”
and “deletion 22q11 syndrome”) and to advocate for peo-
ple with the disorder. The annual meetings of the Edu-
cational Foundation have reached 13,000 professionals
and laypeople since the ﬁrst meeting in 1995.
Society of Craniofacial Genetics.—The Society of Craniofa-
cial Genetics will be meeting on October 9th, 2006, in
conjunction with the American Society of Human Ge-
netics meeting in New Orleans. Submissions for pres-
entation are invited, and should be sent to virginia
.kimonis@childrens.harvard.edu. Information on the So-
ciety of Craniofacial Genetics and a membership appli-
cation are available on the Society’s Web site (http://
craniofacialgenetics.org/).
Symposia
WORLD (We’re Organizing Research on Lysosomal Diseases)
Symposium 2006.—The 3rd annual conference will be pre-
sented by the Lysosomal Disease Network in partnership
with Dr. Chet Whitley, a professor in the Department of
Pediatrics at the University of Minnesota, on December
7–9, 2006, at Disney’s Contemporary Resort in Orlando,
FL. The goal of the annual symposium is to provide an
interdisciplinary forum to explore and discuss speciﬁc
areas of interest related to lysosomal diseases. The sym-
posium is appropriate for clinicians, geneticists and gen-
etic counselors, neurologists and neuropsychologists,
researchers, nurses, and other health care professionals, as
well as patients and families, patient/family support or-
ganizations, and industry professionals. Disease focuses
will include mucopolysaccharidosis, mucolipidosis, oli-
gosaccharidosis, Fabry disease, Batten disease, Gaucher
disease, Pompe disease, and sphingolipidoses. The dead-
line for abstracts is July 1, 2006; for abstract submission,
use the Lysosomal Disease Network Web site (http://
www.lysosomaldiseasenetwork.org). To register, visit the
University of Minnesota’s Continuing Medical Education
Web site (http://www.cme.umn.edu), click “Course Cal-
endar,” and scroll to “WORLD Symposium,” or else con-
tact the University of Minnesota by telephone, at (612)
626-7600 or (800) 776-8636. To make hotel reservations,
call (407) 824-3869, and be sure to mention the WORLD
symposium to receive a discounted room rate. For more
information, contact the Ofﬁce of ContinuingMedical Ed-
ucation at the URL or telephone numbers above or by e-
mail (cmereg@umn.edu). A complete brochure with a de-
tailed agenda will be available this summer. TheUniversity
of Minnesota is accredited by the Accreditation Council
for Continuing Medical Education (ACCME) to provide
continuing medical education to physicians.
